Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Tebivudine tablets (SUV)

Telbivudine is used in adult patients with chronic hepatitis B with evidence of virus replication and continuous increase of serum transaminase (ALT or AST) or evidence of active liver lesions. See the inner packaging instructions for details. More role
App download minus 10 yuan
Common name:
Telbivudine Tablets
Product No.:
B14202006813
Approval No.:
Gyzz h20070028 (inquired by the State Drug Administration)
Jianke price:
¥162.78
Product specification:
600mg*7s
Manufacturer:
beijing novartis pharma ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Tebivudine tablets (SUV)
Main raw materials The main component of this product is telbivudine, chemical name: 1 - ((2S, 4R, 5S) - 4-hydroxy-5-hydroxymethyltetrahydrofuran-2-y1) - 5-methyl-1h-pyrimidine-2,4-dione.
Main role Telbivudine is used in adult patients with chronic hepatitis B with evidence of virus replication and continuous increase of serum transaminase (ALT or AST) or evidence of active liver lesions. See the inner packaging instructions for details.
Product specification 600mg*7s
Usage and dosage The recommended dose is 600mg, once a day, orally, before or after meals, and is not affected by eating. See the inner packaging instructions for details.
manufacturing enterprise beijing novartis pharma ltd
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Tebivudine tablets (SUV)

[common name] Telbivudine Tablets

[specification and model] 600mg*7s

[manufacturer] beijing novartis pharma ltd

[drug type] Western medicine

[approval No.] Gyzz h20070028

[validity period] 24 months

[functional indications] Telbivudine is used in adult patients with chronic hepatitis B with evidence of virus replication and continuous increase of serum transaminase (ALT or AST) or evidence of active liver lesions. See the inner packaging instructions for details.

[usage and dosage] The recommended dose is 600mg, once a day, orally, before or after meals, and is not affected by eating. See the inner packaging instructions for details.

[adverse reactions] The common adverse reactions in foreign clinical studies are weakness, headache, abdominal pain, nausea, (gastrointestinal) flatulence, diarrhea and dyspepsia. This product may cause the CK value of patients to increase. In the telbivudine registration study, the proportion of patients with moderate CK increase significantly, which is 12.9%. Some patients have the tendency of rhabdomyolysis and occasionally myasthenia gravis. See the inner packaging instructions for details.

[precautions] 1. patients stop hepatitis B treatment will have acute exacerbation of hepatitis, including stopping the use of telbivudine. Therefore, patients who stop HBV treatment should monitor liver function by secret work, and if necessary, anti HBV therapy should be carried out again. 2. For patients with renal dysfunction or potential risk of renal dysfunction, chronic treatment with telbivudine can lead to nephrotoxicity. These patients should closely monitor renal function and adjust the dose. 3. The use of nucleoside analogues alone or in combination with other antiretroviral drugs can lead to lactic acidosis and severe hepatomegaly with steatosis, including fatal events. 4. Because the risk of developing human embryos is not clear, it is suggested that women of childbearing age treated with telbivudine should take effective contraceptive measures. See the inner packaging instructions for details. Please read the instructions carefully and follow the doctor's advice.

[taboo] This product is forbidden to be used in patients who have been proved to be allergic to telbivudine and any other components of this product. This product shall not be mixed with pegylated interferon α- 2a, because the combination of the two can increase the risk of peripheral neuropathy.

[listing Permit Holder] beijing novartis pharma ltd

[packaging unit] box

[main ingredients] The main component of this product is telbivudine, chemical name: 1 - ((2S, 4R, 5S) - 4-hydroxy-5-hydroxymethyltetrahydrofuran-2-y1) - 5-methyl-1h-pyrimidine-2,4-dione.

[character] This product is a film coated tablet, which turns white to yellowish after removing the coating.

[applicable population] adult

[medication for pregnant and lactating women] Telbivudine can be secreted into the milk of rats, but the effect of telbivudine on pregnant women and mother to child transmission of HBV has not been studied; At present, it is not known whether telbivudine will secrete into human milk, so lactating women should avoid lactation. See the inner packaging instructions for details.

[medication for children] The efficacy and safety of telbivudine in patients under 16 years of age are not clear. This product is not suitable for children and teenagers.

[medication for elderly patients] The efficacy and safety of telbivudine in elderly patients over 65 years old have not been clear. Considering the renal function damage caused by various complications in the elderly, when using this product, the patient's renal function should be monitored and the dose and usage of the drug should be adjusted accordingly.

[storage] Store under 30 ℃ y

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Tebivudine tablets (SUV)

    ¥162.78

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!